Dorsey & Whitney Trust Company Decreased Conocophillips (COP) Stake by $677,750; Share Value Declined; Edwards Lifesciences Corpora (EW) Holder Kames Capital Plc Boosted Its Holding by $749,593 as Market Valuation Rose

January 10, 2018 - By Ellis Scott

Kames Capital Plc increased its stake in Edwards Lifesciences Corpora (EW) by 60.61% based on its latest 2017Q3 regulatory filing with the SEC. Kames Capital Plc bought 6,877 shares as the company’s stock rose 25.80% with the market. The institutional investor held 18,224 shares of the industrial specialties company at the end of 2017Q3, valued at $1.99 million, up from 11,347 at the end of the previous reported quarter. Kames Capital Plc who had been investing in Edwards Lifesciences Corpora for a number of months, seems to be bullish on the $25.04B market cap company. The stock decreased 1.00% or $1.2 during the last trading session, reaching $118.31. About 208,063 shares traded. Edwards Lifesciences Corporation (NYSE:EW) has risen 15.41% since January 10, 2017 and is uptrending. It has underperformed by 1.29% the S&P500.

Dorsey & Whitney Trust Company Llc decreased its stake in Conocophillips (COP) by 31.25% based on its latest 2017Q3 regulatory filing with the SEC. Dorsey & Whitney Trust Company Llc sold 13,555 shares as the company’s stock declined 0.06% while stock markets rallied. The institutional investor held 29,818 shares of the integrated oil company at the end of 2017Q3, valued at $1.49 million, down from 43,373 at the end of the previous reported quarter. Dorsey & Whitney Trust Company Llc who had been investing in Conocophillips for a number of months, seems to be less bullish one the $69.44B market cap company. The stock increased 0.27% or $0.155 during the last trading session, reaching $58.085. About 1.32M shares traded. ConocoPhillips (NYSE:COP) has risen 9.50% since January 10, 2017 and is uptrending. It has underperformed by 7.20% the S&P500.

Kames Capital Plc, which manages about $3.65 billion US Long portfolio, decreased its stake in Pfizer Inc. (NYSE:PFE) by 32,190 shares to 765,654 shares, valued at $27.32M in 2017Q3, according to the filing. It also reduced its holding in First Republic Bank (NYSE:FRC) by 21,473 shares in the quarter, leaving it with 955,980 shares, and cut its stake in Amphenol Corporation (NYSE:APH).

Among 28 analysts covering Edwards Lifesciences Corp (NYSE:EW), 21 have Buy rating, 1 Sell and 6 Hold. Therefore 75% are positive. Edwards Lifesciences Corp had 93 analyst reports since July 30, 2015 according to SRatingsIntel. The rating was maintained by Citigroup on Wednesday, April 27 with “Sell”. The rating was upgraded by BTIG Research on Monday, April 4 to “Buy”. The firm earned “Sell” rating on Thursday, November 12 by Citigroup. The stock of Edwards Lifesciences Corporation (NYSE:EW) earned “Equal-Weight” rating by Barclays Capital on Thursday, April 7. Canaccord Genuity maintained it with “Buy” rating and $15500 target in Thursday, July 27 report. RBC Capital Markets maintained Edwards Lifesciences Corporation (NYSE:EW) on Monday, October 2 with “Buy” rating. The company was maintained on Wednesday, October 26 by Stifel Nicolaus. On Monday, April 4 the stock rating was maintained by Jefferies with “Buy”. Barclays Capital maintained the stock with “Equal-Weight” rating in Wednesday, October 25 report. Zacks downgraded the shares of EW in report on Tuesday, September 22 to “Hold” rating.

Dorsey & Whitney Trust Company Llc, which manages about $502.84M US Long portfolio, upped its stake in Schlumberger Ltd (NYSE:SLB) by 5,803 shares to 95,454 shares, valued at $6.66M in 2017Q3, according to the filing. It also increased its holding in Ishares Core S&P 500 Etf (IVV) by 5,697 shares in the quarter, for a total of 16,452 shares, and has risen its stake in Home Depot Inc (NYSE:HD).

Among 25 analysts covering ConocoPhillips (NYSE:COP), 17 have Buy rating, 1 Sell and 7 Hold. Therefore 68% are positive. ConocoPhillips had 83 analyst reports since August 4, 2015 according to SRatingsIntel. The firm earned “Outperform” rating on Friday, October 27 by Wells Fargo. The rating was downgraded by Oppenheimer on Tuesday, August 4 to “Perform”. The company was downgraded on Thursday, May 11 by Bank of America. Cowen & Co maintained ConocoPhillips (NYSE:COP) rating on Friday, March 31. Cowen & Co has “Outperform” rating and $59 target. The rating was maintained by RBC Capital Markets on Thursday, November 9 with “Buy”. The stock of ConocoPhillips (NYSE:COP) has “Underperform” rating given on Thursday, April 21 by Jefferies. The stock has “Buy” rating by Jefferies on Wednesday, May 17. On Friday, October 28 the stock rating was upgraded by Piper Jaffray to “Overweight”. Credit Suisse initiated the stock with “Hold” rating in Monday, December 11 report. Bernstein downgraded the shares of COP in report on Thursday, July 6 to “Market Perform” rating.

Analysts await ConocoPhillips (NYSE:COP) to report earnings on February, 1. They expect $0.40 earnings per share, up 253.85% or $0.66 from last year’s $-0.26 per share. COP’s profit will be $478.21M for 36.30 P/E if the $0.40 EPS becomes a reality. After $0.16 actual earnings per share reported by ConocoPhillips for the previous quarter, Wall Street now forecasts 150.00% EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.